Form 10-Q IDENIX PHARMACEUTICALS For: Jun 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Idenix Pharmaceuticals (IDIX) Misses Q2 EPS by 22c
July 31, 2014 4:34 PM EDTIdenix Pharmaceuticals (NASDAQ: IDIX) reported Q2 EPS of ($0.43), $0.22 worse than the analyst estimate of ($0.21).
For earnings history and earnings-related data on Idenix Pharmaceuticals (IDIX) click here.
... More


